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E-mail address: maria.a.mena@hrc.es (M.A. Mena)Parkin mutations produce Parkinson’s disease (PD) in humans and nigrostriatal dopamine lesions
related to increased free radicals in mice. We examined the effects of NP7, a synthetic, marine
derived, free radical scavenger which enters the brain, on H2O2 toxicity in cultured neurons and glia
from wild-type (WT) and parkin null mice (PK-KO).
NP7, 5–10 lM, prevented the H2O2 induced apoptosis and necrosis of midbrain neuronal and
glial cultures from WT and PK-KO mice. NP7 suppressed microglial activation and the H2O2 induced
drop-out of dopamine neurons. Furthermore, NP7 prevented the increased phosphorylation of ERK
and AKT induced by H2O2. NP7 may be a promising neuroprotector against oxidative stress in PD.
 2008 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Parkinson’s disease (PD) is a neurodegenerative disorder of
multifactorial origin [1–3]. The majority of the cases are sporadic
and of unknown origin [4] and in most cases it is considered that
the drop-out of nigrostriatal dopamine neurons, one of the land
marks of the disease, could be mediated by multiple mechanisms
including genetic abnormalities of several proteins, aging, accumu-
lation of free radicals, mitochondrial dysfunction and others [4–6].
Mutations of Park-2, a gene which codes for parkin, a protein
with ubiquitin ligase function, are the most common cause of auto-
somal recessive parkinsonism in humans world wide [7–9]. The
pathogenic mechanism of parkin related PD is considered, at least
partly, to be due to excessive free radical formation in the intracel-
lular mono amino oxidase (MAO) mediated metabolism of dopa-
mine (DA) [10,11]. The suppression of parkin impairs the release
of dopamine and shifts its metabolism to dihydroxy-phenyl-aceticchemical Societies. Published by E
.acid (DOPAC), producing a molecule of H2O2 per molecule of DA
[10–12].
Parkin null mice, while young, are able to compensate the
excessive free radical production, due to their abnormal metabo-
lism of DA, with an increased production of glutathione (GSH)
[10] and, therefore, are more resistant than wild-type (WT) to
L-DOPA toxicity [12], which is also mediated by increased free rad-
ical production through the metabolism of catecholamines, or to
other free radical producing neurotoxins such as nitric oxide
[13]. But parkin null cells are more susceptible to additional insults
such as treatment with rotenone, a mitochondrial toxin [14], cal-
cium channel antagonists, such as cinnarizine [15] or to the effects
of aging, when the supportive function of glia is reduced and the
increased production of GSH collapses [16].
Parkin enhances the survival of the dopamine neurons [14,17–
21]. Parkin dysfunction impairs astrocytic function and contributes
to the pathogenesis of parkin-linked AR-PD [22]. Furthermore, a
reduction in parkin levels renders the rat glial-like cell line RG-6
more susceptible to dopamine (DA)- and H2O2-induced cell death
[23]. In PK-KO aging midbrain glia, low H2O2 concentration in-
duced cell death [16].lsevier B.V. All rights reserved.
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cals is the key pathogenic mechanism for the death of the nigrostri-
atal dopamine neurons in parkin related PD and that if the
increased production of GSH is able to compensate such increase
in free radicals as long as it lasts, the treatment of parkin null ner-
vous cells with free radical scavengers will reduce the cell death of
DA neurons. Here we report the neuroprotective effects of NP7 in
parkin null dopamine neurons and glial cells challenged with H2O2.
NP7 is a new antioxidant, marine derived, with a different
chemical molecular structure that the classic phytochemicals, ob-
tained by lead optimization system from the Streptomyces species,
with free radical scavenger properties in the sub lM–nM range and
which crosses the blood brain barrier in mammals [24].2. Materials and methods
2.1. Materials
Drugs, culture media, chemical reagents and antibodies. NP7 was
provided by Noscira from a group of synthetic, marine derived
antioxidants. Culture media and antibodies were used as previ-
ously described [12,16] and are detailed in Supplementary
material.
2.2. Cell cultures
Neuronal-enriched and glial mesencephalic cultures were ob-
tained from 129SV/C57BL6 WT or parkin mutant mice (PK-KO) as
previously described [10,12,16]. In accordance with the EuropeanFig. 1. Effects of NP7 on hydrogen peroxide-induced toxicity in neuronal-enriched mese
1 h with 5 lMNP7 in EMEM + D-glucose medium and then was added 50 lMH2O2 for two
of apoptotic cells with respect to the total number. (C) Number of DA neurons expressed
immunoreactivity of astroglial (GFAP+) cells. Values are the mean ± S.E.M. of three–four i
one-way ANOVA followed by Newman–Keuls multiple comparison test. ***P < 0.001 H
corresponding H2O2 treatments alone.Union Directives, all efforts were made to minimize the number
of animals used and their suffering.
Neuronal-enriched mesencephalic and glial cultures were ob-
tained and prepared as previously described [12,16,25]. Culture
medium from glial cultures was refreshed after 6–7 days and every
7 days thereafter. After 18 days in culture, positive staining with
anti-GFAP antibody identiﬁed the astrocytes in these cultures
and contained at least 80–90% of total cells.
2.3. Cell treatments
WT and PK-KO neuronal-enriched midbrain cultures, main-
tained for 7 days in vitro (DIV), were seeded with a density of
250.000 cells in P24 multiwells or 200.000 cells in cover-slides,
for immunocytochemistry (ICQ) studies. For the curve dose–
response experiments, the cultures were treated for 3 h with
increasing concentrations of NP7. In another set of experiments,
WT and PK-KO cultures were treated with NP7 (5–10 lM)
60 min before the treatment with H2O2 (50 lM). The growth
medium was changed to EMEM plus D-glucose (6 mg/ml), the most
appropriate medium for H2O2 stability, for the experiments with
hydrogen peroxide.
Glial cell treatments. After 15–20 DIV in the growth medium
(DMEM-FCS), glial cultures had reached conﬂuent; at this time,
the cells were mildly trypsinized and reseeded for the experiments
at a density of 1.3  104 cells/cm2 in 24- 12-well plates cultures and
maintained in growth medium for 6–7 additional days. In the
experiments, the cultures were treated 90 min before H2O2
(100 lM) treatment with NP7 at the different concentrations
tested. In the experiments with H2O2, the growth medium wasncephalic cultures from WT mice. After 7 days in vitro, the cells were pretreated for
additional hours. (A) Mitochondrial activity measured by MTT assay. (B) Percentage
as percentage of TH+ cells (TH+ cells in control, 450 ± 10). (D) Optical intensity of the
ndependent cultures with six replicates each. Statistical analysis was performed by
2O2 treated cultures vs. controls, DDDP < 0.001 H2O2 treatment plus NP7 vs. the
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iments, we used aged glial cultures maintained in culture for 5–7
months, changing the growth medium (DMEM-FCS) every week.
2.4. Cellular characterization and viability, anti-oxidants and
pro-oxidants
DA neurons were characterized by immunostaining with a
mouse anti-TH antibody (1:500) and astrocytes with a rabbit
anti-GFAP antibody (1:500); microglial cells were identiﬁed with
isolectin B4 peroxidase-labelled (12.5 lg/ml) [26,27]. The number
of immunoreactive cells was counted in one-seventh of the total
area of the cover-slides. The cells were counted in predeﬁned par-
allel strips using a counting reticule inserted into the ocular.
Cell viability was analyzed with the mitochondrial activity
assay which measures the metabolism of 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyl tetrazolium bromide (MTT). Apoptosis was
measured by light microscopy, DNA staining with bis-benzimide
(Hoechst 33342) and the TUNEL assay [16,28,29]. Necrosis was
measured according to lactate dehydrogenase activity [30] in the
culture medium and by trypan blue dye exclusion in cells [29].
Total glutathione, reduced glutathione (GSH) and oxidized glu-
tathione (GSSG) were measured by the methods of Tietze [31] and
Grifﬁth [32], respectively. The concentration of H2O2 was esti-
mated with a colorimetric assay; 3,30-dimethoxybenzidine, which
is colourless in its reduced form, is oxidized in the presence of
H2O2 and peroxidased into a red-coloured product [16]. The con-
centration of intracellular iron in midbrain glial cultures was esti-
mated by the colorimetric ferrozine assay [33].Fig. 2. Effects of NP7 on cell viability and H2O2 detoxiﬁcation in neuronal-enriched mes
cells, 60 min before the treatment with H2O2 (50 lM) for 2 h, received 10 lM of NP7. (A)
10 min post-treatment with H2O2, 50 lM. (D) Percentage of apoptosis, condensated and f
treated with solvent, H2O2 (50 lM) or H2O2 plus NP7 (10 lM). (E) Photomicrographs o
fragmented cells obtained by the TUNEL assay corresponding to the same ﬁeld. Scale bar
by TUNEL assay. (F) Percentage of apoptotic-fragmented cells by TUNEL assay. Values
Statistical analysis was performed by two-way ANOVA (the interaction between genotyp
***P < 0.001 H2O2 treated cultures vs. controls, ++P < 0.01; +++P < 0.001 PK-KO vs. WT
corresponding H2O2 treatments alone.2.5. Western blot analysis
The levels of proteins involved in signaling of survival
responses, pERK and IP3/AKT pathways, were measured by
Western blot according to previously described techniques. We
used a mouse anti-phospho-ERK-1/2 and rabbit anti-ERK-1/2
antibodies from Sigma (Madrid, Spain) diluted 1:5000 and
1:10000, respectively. Rabbit anti-phosphorylated AKT and rabbit
polyclonal anti AKT antibodies from Cell-Signaling (Boston, MA,
USA) at 1/400 each [16,25,34].
2.6. Statistical analysis
The statistical evaluation was performed by two-way analysis
of variance followed by the Bonferroni test, or by one-way ANOVA
followed by Newman–Keuls test, using the GraphPad PRISM 4 soft-
ware. Differences were considered signiﬁcant when P < 0.05.3. Results and discussion
3.1. Effects of NP7 on H2O2 toxicity in midbrain neuronal cultures from
WT and PK-KO mice
The curve dose–response at concentrations of NP7 from 0.5 to
10 lM did not show any toxicity in the MTT assay (data not
shown). NP7, 5 lM, 60 min before the treatment with H2O2
(50 lM), prevented partially the effects of H2O2 on mitochondrial
activity (H2O2-treated groups had a 81% decreased vs. WT andencephalic cultures from WT and PK-KO mice. After 7 days in vitro, WT and PK-KO
Mitochondrial activity (MTT assay). (B) LDH activity. (C) H2O2 levels in the medium
ragment cells staining with bis-benzimide, in WT and PK-KOmesencephalic cultures
f total nuclei stained with bis-benzimide and positive co-localization of apoptotic-
= 30 lm. Ampliﬁed inset shows that chromatin-condensed nuclei are not comarked
are the mean ± S.E.M. of two–three independent cultures with six replicates each.
e and treatment was P < 0.01) followed by Bonferroni post-test. *P < 0.05; **P < 0.01;
cultures; DP < 0.05; DDP < 0.01; DDDP < 0.001 H2O2 treatment plus NP7 vs. the
Fig. 4. NP7 protects WT and PK-KO midbrain glial cultures from cell death induced by H2O2. Glial cultures maintained during 20–30 DIV in DMEM + 15% FCS were used for
these experiments; 6–7 days after reseeding, the cells were treated with 100 lM of H2O2 for 2 h in EMEM + D-glucose; 90 min before treatment pre-established groups were
treated with NP7 (0.5 or 5 lM). (A) Mitochondrial and LDH (B) activities in WT glial cultures pre-exposed to 0.5 and 5 lM of NP7 previous to H2O2 100 lM treatment. (C)
Photomicrographs showing trypan blue dye exclusion and (D) number of necrotic cells in WT glial cultures. (E) LDH activity in WT and PK-KO glial cells treated with H2O2
(100 lM), solvent or H2O2 (100 lM) plus NP7 (5 lM). (F) Intracellular glutathione. (G) Levels of H2O2 in the medium. Values are the mean ± S.E.M. of two independent
cultures with six replicates each. Statistical analysis was performed by one- or two-way ANOVA (the interaction between genotype and treatment was P < 0.01) followed by
Newman–Keuls multiple comparison test and Bonferroni post-test, respectively. *P < 0.05; **P < 0.01; ***P < 0.001 H2O2 treated cultures vs. controls, +P < 0.05; ++P < 0.01;
+++P < 0.001 PK-KO vs. WT cultures; DP < 0.05, DDP < 0.01, DDDP < 0.001 H2O2 treatment plus NP7 vs. the corresponding H2O2 treatments alone.
Fig. 3. EffectsofNP7ondopamineneuronsandmicroglial cells inmesencephaliccultures fromWTandPK-KOmice.After7days invitro, thecellsweretreatedwithH2O2 (50 lM)for2 h;NP7,
10 lM,wasaddedtopre-establishedgroups60minbefore theperoxide. (A)PhotomicrographsofDAneurons(TH+cells), scalebar = 30 lm.(B)DAneuronsexpressedaspercentageofTH+ (TH+
cells inWTcontrol, 427 ± 11;TH+ cells inPK-KOcontrol, 411 ± 10). (C)Photomicrographs showingmicroglial (IsolectinB4+) cells, scalebar = 30 lm. (D)Percentageofmicroglial cells present in
WT and PK-KOmidbrain cultures (Isolectin B4+ cells inWT and PK-KO controls were 448 ± 8 and 749 ± 48, respectively). Values are themean ± S.E.M. of two independent cultures with six
replicates each. Statistical analysiswasperformedbyone-wayANOVA followedbyNewmanKeulsmultiple comparison test. *P < 0.05; **P < 0.01; ***P < 0.001H2O2 treated cultures vs. controls,
+P < 0.05 PK-KO vs.WT cultures; DP < 0.05; DDP < 0.01; DDDP < 0.001 H2O2 treatment plus NP7 vs. the corresponding H2O2 treatments alone.
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Fig. 5. Effect of NP7 on H2O2-induced toxicity in aged WT and PK-KO glial cultures.
Glia cultures maintained for 5–7 months in DMEM + 15% FCS were used for these
experiments. (A) LDH activity in WT and PK-KO aged cultures treated for 2 h in
EMEM + D-glucose with H2O2 (50 lM); 90 min before the peroxide treatment, pre-
established groups received NP7 (5 lM). (B) H2O2 remnant in the medium after
10 min post-treatment with H2O2 (50 lM and 100 lM). Values are the mean ±
S.E.M. of two independent cultures with six replicates each. Statistical analysis was
performed by one-way ANOVA followed by Newman–Keuls multiple comparison
test. **P < 0.01; ***P < 0.001 H2O2 treated cultures vs. controls, +P < 0.05; +++P < 0.001
PK-KO vs. WT cultures, DDP < 0.01; DDDP < 0.001 H2O2 treatment plus NP7 vs. the
corresponding H2O2 treatments alone.
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apoptosis (H2O2-treated groups had a 52%, NP7 + H2O2 prevented
to a 15% increased vs. the 5.9% of WT control) (Fig. 1B). However,
NP7, 5 lM, prevented totally the drop-out of dopamine (TH+) neu-
rons (Fig. 1C) and astroglia activation (Fig. 1D). Therefore, NP7,
when administered before H2O2 has a potent neuroprotective ef-
fect in WT midbrain neuronal-enriched cultures.
We have previously shown that WT and PK-KO neuronal-en-
riched cultures grown in B27/NBL serum-free deﬁned medium
for 7–8 days in vitro are formed by 80% neurons (MAP-2+), of which
around 1–2% are DAergic (TH+), and 10–15% glia, mostly astrocytes
(GFAP+), glial progenitors (A2B5), microglia (isolectin B4) and oli-
godendrocytes (O1+); the rest are nestin+ neuronal progenitors
[12].
Now, we have compared the neuroprotective effects of NP7 on
WT and PK-KO midbrain neurons. In both types of neurons, H2O2
altered and NP7, 10 lM, prevented the decreased MTT metabolism,
from 40% to 70% in H2O2 and NP7 + H2O2 treated groups vs. con-
trols, respectively (Fig. 2A). LDH increased activity-induced by
H2O2 was totally prevented with NP7, 10 lM (Fig. 2B), as well as
the remaining H2O2 levels in the medium (Fig. 2C) and the percent-
age of apoptotic cells (Fig. 2D–F). As expected, after 2 h of H2O2
treatment, we observed a higher increase in early condensated-
apoptotic cells, measured by bis-benzimide staining (Fig. 2D and
E) than in fragmented-apoptotic cells valued by the TUNEL assay
(Fig. 2E and F).
The percentage of TH+ neurons loss (Fig. 3A and B) and the acti-
vation of microglial cells were totally prevented with NP7, 10 lM
(Fig. 3C and D). In general, the effects and counter effects of H2O2
and NP7, respectively, on these parameters were similar in both
WT and PK-KO mice, but there were some very interesting excep-
tions worthy of discussion. The levels of H2O2 were signiﬁcantly
lower in H2O2 treated PK-KO neurons than in H2O2 treated WT
and, accordingly, the drop-out of TH+ neurons after H2O2 treatment
was less severe in PK-KO than in WT cultures. We have described
that PK-KO mice have greater levels of GSH in brain than their WT
controls, perhaps as a mechanism of compensation of the chronic
increased production of free radicals which they have. These in-
creased GSH levels could work as a scavenging mechanism for
H2O2, reducing its levels and its toxicity.
3.2. NP7 protects WT and PK-KO midbrain glial cultures from cell
death induced by H2O2
In this work, we found that NP7 protects astroglial cells from
WT and PK-KO neuronal-enriched cultures from the H2O2 toxicity.
In WT glial cultures treated with H2O2, NP7 restores MTT levels
from concentrations of 0.5 lM (Fig. 4A) and has a dose-dependent
effect on the reversal of the elevation of LDH levels from 0.5 to
5 lM (Fig. 4B). At a concentration of 5 lM, NP7 completely blocks
necrosis in H2O2 treated WT glia (Fig. 4C–E). As in the case of neu-
ronal cultures, H2O2 toxicity is less marked in PK-KO than in WT
glial cultures. The role of GSH in the differences between WT and
PK-KO cells is shown in Fig. 4F. PK-KO cells have a 128% increased
GSH levels vs. WT, and NP7 did not protected from the H2O2-in-
duced decreased in GSH (Fig. 4F). The treatment with H2O2 and
NP7 does not alter the levels of iron in WT or PK-KO glia (data
not shown). As expected, the treatment with H2O2 increases the
H2O2 levels in WT and PK-KO glia but the co-treatment with NP7
slightly reduced them, from 375% to 275% in WT and from 180%
to 130% en PK-KO cultures (Fig. 4G).
3.3. Effect of NP7 on H2O2 toxicity in aged glial cultures
PD and other neurodegenerative disorders affect mature or se-
nile patients and we have observed that neurochemical deﬁcitsin PK-KO mice increase with age [20,21,35]. Therefore, we have
investigated the effects of H2O2 and NP7 on midbrain glia main-
tained in growth medium (DMEM-FCS) for 5–7 months, changing
the growth medium (DMEM-FCS) every week. Aged PK-KO glial
cells are more sensitive than aged WT to H2O2 [16], so we treated
glial cultures with lower concentrations of H2O2, 50 lM. At this
concentration of H2O2, WT glia does not produce elevation of
LDH (Fig. 5A). The levels of LDH, which are greater in untreated
aged PK-KO glia than in untreated aged WT, greatly increase with
the treatment with H2O2, 50 lM, an effect which is almost com-
pletely prevented by NP7, 5 lM (from a 204% increased in H2O2
to a 129% in NP7 + H2O2) (Fig. 5A). As expected, the treatment with
H2O2, 50 lM, increased the levels of H2O2 in WT and much more in
PK-KO aged glia (Fig. 5 B). Baseline H2O2 levels were also greater in
PK-KO than in WT glia (Fig. 5B). In summary, our data suggest that
aged PK-KO glia has difﬁculties in handling the endogenous pro-
duction of H2O2 and becomes very susceptible to relatively small
concentrations of this oxidating agent which appear to be well tol-
erated by WT aged glia.
M.A. Mena et al. / FEBS Letters 583 (2009) 168–174 1733.4. Effects of oxidative stress and NP7 in signaling pathways
H2O2 and other free radical generating agents induce a strong
activation of ERKs, JNKs and p38-MAPK on many cellular signaling
systems [34,36,37]. Parkin and DJ-1 lead to impairments of oxida-
tive stress response and PI3K/AKT signaling [38,39]. In young (18–
30 DIV) WT glial cultures, treatment with H2O2 produced a rapid
and progressive ERK phosphorylation, as measured by the ratio
p-ERK/ERK, from 15 to 60 min after treatment (data not shown).
NP7, 5 lM protected from p-ERK activation in young glial cultures
from WT (465% increased with H2O2 and 300% with NP7 + H2O2)
and PK-KO mice (438% increased with H2O2 and 305% with
NP7 + H2O2) (Fig. 6A) and from the H2O2 induced p-AKT activation
(424% increased with H2O2 and 285% with NP7 + H2O2 in WT and
322% increased with H2O2 and 222% with NP7 + H2O2 in PK-KO
mice) (Fig. 6B).
Aged PK-KO glia is more sensitive to oxidative stress than WT,
and H2O2 induced a higher p-ERK (254% increased with H2O2 and
106% with NP7 + H2O2 in WT and 629% increased with H2O2 andFig. 6. Effects of H2O2 and NP7 on p-ERK and p-AKT signaling pathways. Young and aged
days after reseeding, the cells were treated with 100 lM of H2O2 for 30 min in EMEM +
(5 lM). (A) p-ERK signaling pathway in young glia cultures. (B) p-AKT signaling pathway
signaling pathway in aged glia cultures. Values are the mean ± S.E.M. of three independen
way ANOVA (the interaction between aged glia genotype and treatment was P < 0.01
respectively. ***P < 0.001 H2O2 treated cultures vs. controls, +++P < 0.001 PK-KO vs. W
corresponding H2O2 treatments alone.139% with NP7 + H2O2 in PK-KO mice) (Fig. 6C) and p-AKT activa-
tion (385% increased with H2O2 and 213% with NP7 + H2O2 in WT
and 1246% increased with H2O2 and 526% with NP7 + H2O2 in
PK-KO mice) (Fig. 6D). NP7 protected very effectively in aged glial
cultures from the p-ERK (Fig. 6C) and from the p-AKT activation
(Fig. 6D). The special sensitivity of aged PK-KO glia to oxidative
stress while there is strong resistance in young PK-KO cells, sug-
gest that these cells are exposed to a greater oxidative challenge
and that a compensatory GSH synthesis is increased for some time
until it collapses with senescence and renders the cells more sus-
ceptible [16]. Furthermore, in the differential oxidative stress re-
sponse between WT and PK-KO cultures, parkin as an E3 ligase,
which participates in the ubiquitin–proteasome system, protein
aggregation and protein posttranslational modiﬁcations, may play
a very important role [40–43].
In summary, NP7 has a strong protective effect in free radical
related stress in neurons and glia from WT and PK-KO mice and,
may therefore be a promising candidate for neuroprotection
against oxidative stress in PD.glial cultures maintained in DMEM + 15% FCS were used for these experiments; 6–7
D-glucose; 90 min before treatment, pre-established groups were treated with NP7
in young glia cultures. (C) p-ERK signaling pathway in aged glia cultures. (D) p-AKT
t cultures with six replicates each. Statistical analysis was performed by one- or two-
) followed by Newman–Keuls multiple comparison test and Bonferroni post-test,
T cultures, DP < 0.05; DDP < 0.01; DDDP < 0.001 H2O2 treatment plus NP7 vs. the
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